Document ID: chunk:federal_register_of_legislation:F2020L00493:reg:9:p3
Version: federal_register_of_legislation:F2020L00493
Segment Type: reg
Provision Reference: reg 9 (pt 3/3)
Character Range: 9269–11712

liver;
(19)      an inability to undertake any physical activity greater than three METs for at least ten years within the 15 years before the clinical onset of malignant neoplasm of the liver;
Note: MET is defined in the Schedule 1 - Dictionary.
(20)      using the combined oral contraceptive pill for a continuous period of at least three years before the clinical onset of malignant neoplasm of the liver, and where the use of the combined oral contraceptive pill has ceased, the clinical onset of malignant neoplasm of the liver has occurred within 30 years of cessation;
Note: combined oral contraceptive pill is defined in the Schedule 1 - Dictionary.
(21)      taking or being treated with an anabolic-androgenic steroid:
(a)          for a continuous period of at least three years; and
(b)          to a cumulative total of at least 14 grams; and
(c)          where the cumulative total dose of anabolic-androgenic steroid was taken at least five years before the clinical onset of malignant neoplasm of the liver; and
(d)          where taking or being treated with the steroid has ceased, the clinical onset of malignant neoplasm of the liver has occurred within 20 years of cessation;
(22)      chewing betel quid or areca nut on more days than not, for at least five years before the clinical onset of malignant neoplasm of the liver, and where chewing of betel quid or areca nut has ceased, the clinical onset has occurred within 20 years of cessation;
(23)      being exposed to arsenic as specified before the clinical onset of malignant neoplasm of the liver, where the first exposure to arsenic occurred at least ten years before the clinical onset of malignant neoplasm of the liver;
Note: being exposed to arsenic as specified is defined in the Schedule 1 - Dictionary.
(24)      having steatohepatitis for at least five years before the clinical onset of malignant neoplasm of the liver;
(25)      having autoimmune chronic active hepatitis or primary biliary cholangitis before the clinical onset of malignant neoplasm of the liver;
Note: autoimmune chronic active hepatitis is defined in the Schedule 1 - Dictionary.
(26)      having a disorder from the specified list of disorders before the clinical onset of malignant neoplasm of the liver;
Note: specified list of disorders is defined in the Schedule 1 - Dictionary.
(27)      inability to obtain appropriate clinical management for malignant neoplasm of the liver.